摘要 : BackgroundThe emergence of novel and efficient antibody maintenance approaches has provided more options for post-induction treatment of advanced follicular lymphoma (FL), and further comparisons are required to determine the most... 展开
作者 | Chu~ Yurou Liu~ Yingyue Yu~ Zhuoya Zhan~ Linquan Lu~ Tiange Jiang~ Yujie Fang~ Xiaosheng Zhou~ Xiangxiang Wang~ Xin |
---|---|
期刊名称 | 《Cancer.》 |
总页数 | 11 |
语种/中图分类号 | en / R73 |
关键词 | consolidation follicular lymphoma maintenance obinutuzumab rituximab RITUXIMAB MAINTENANCE RADIOIMMUNOTHERAPY CONSOLIDATION PLUS RITUXIMAB FOLLOW-UP THERAPY OBINUTUZUMAB SURVIVAL EFFICACY ANTIBODY PHASE-3 |
馆藏号 | N2007EPST0000192 |